Peroxisome proliferator-activated receptor alpha is an essential factor in enhanced macrophage immune function induced by angiotensin-converting enzyme
Increased expression of angiotensin-converting enzyme (ACE) by myeloid lineage cells strongly increases the immune activity of these cells, as observed in ACE10/10 mice, which exhibit a marked increase in antitumor and antibactericidal immunity. We report that peroxisome proliferator-activated receptor alpha (PPARα), a transcription factor that regulates genes critical for lipid metabolism, is a key molecule in the enhanced macrophage function induced by ACE. Here, we used a Cre-LoxP approach with LysM-Cre to create a modified ACE10/10 mouse line in which macrophages continue to generate abundant ACE but in which monocyte and macrophage PPARα expression is selectively suppressed. These mice, termed A10-PPARα-Cre, have significantly increased growth of B16-F10 tumors compared with ACE10/10 mice with Cre expression. PPARα depletion impaired cytokine production and antigen-presenting activity in ACE-expressing macrophages, resulting in reduced tumor antigen-specific CD8<sup>+</sup> T-cell generation. Additionally, the elevated bactericidal resistance typical of ACE10/10 mice was significantly reduced in A10-PPARα-Cre mice, such that these mice resembled WT mice in their resistance to methicillin-resistant Staphylococcus aureus (MRSA) infection. THP-1 cells expressing increased ACE (termed THP-1-ACE) constitute a human macrophage model with increased PPARα that shows enhanced cytotoxicity against tumor cells and better phagocytosis and killing of MRSA. RNA silencing of PPARα in THP-1-ACE cells reduced both tumor cell death and bacterial phagocytosis and clearance. In contrast, the in vivo administration of pemafibrate, a specific agonist of PPARα, to WT and A10-PPARα-Cre mice reduced B16-F10 tumor growth by 24.5% and 25.8%, respectively, but pemafibrate reduced tumors by 57.8% in ACE10/10 mice. With pemafibrate, the number of antitumor CD8<sup>+</sup> T cells was significantly lower in A10-PPARα-Cre mice than in ACE10/10 mice. We conclude that PPARα is important in the immune system of myeloid cells, including wild-type cells, and that its increased expression by ACE-expressing macrophages in ACE10/10 mice is indispensable for ACE-dependent functional upregulation of macrophages in both mice and human cells.
Authors
- Jennifer E. Van Eyk (ORCID: https://orcid.org/0000-0001-9050-148X)
- Anthony E. Jones (ORCID: https://orcid.org/0000-0003-2058-6021)
- Ellen A. Bernstein (ORCID: https://orcid.org/0000-0003-3597-9653)
- Suguru Saito (ORCID: https://orcid.org/0000-0003-2235-8866)
- Ajit S. Divakaruni (ORCID: https://orcid.org/0000-0002-2528-9651)
- Aleksandr Stotland (ORCID: https://orcid.org/0000-0003-4794-1097)
- Érika E. Nishi (ORCID: https://orcid.org/0000-0003-3277-4249)
- Tomohiro Shibata (ORCID: https://orcid.org/0000-0002-8766-4250)
- Zakir Khan (ORCID: https://orcid.org/0000-0002-7944-491X)
- Duo‐Yao Cao (ORCID: https://orcid.org/0000-0002-0455-4655)
- Aoi Hoshi
- Kenneth E. Bernstein (ORCID: https://orcid.org/0000-0001-5435-8663)
- Amy Rios
Institutions
- Cedars-Sinai Medical Center (US)
- University of Tsukuba (JP)
- University of California, Los Angeles (US)
- Cedars-Sinai Smidt Heart Institute (US)
- Universidade Federal de São Paulo (BR)
Publication Details
- Journal
- Cellular and Molecular Immunology
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1038/s41423-025-01257-y
- Citations
- 4
- Primary Topic
- Peroxisome Proliferator-Activated Receptors
- Type
- article
- Field-Weighted Citation Impact
- 3.22
Funders
- American Heart Association
- Cedars-Sinai Medical Center
- Université de Lausanne
- National Institutes of Health